0001144204-12-048422.txt : 20120828
0001144204-12-048422.hdr.sgml : 20120828
20120828162546
ACCESSION NUMBER: 0001144204-12-048422
CONFORMED SUBMISSION TYPE: N-PX
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120630
FILED AS OF DATE: 20120828
DATE AS OF CHANGE: 20120828
EFFECTIVENESS DATE: 20120828
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: GMO Series Trust
CENTRAL INDEX KEY: 0001521894
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0228
FILING VALUES:
FORM TYPE: N-PX
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-22564
FILM NUMBER: 121060304
BUSINESS ADDRESS:
STREET 1: 40 ROWES WHARF
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-346-7646
MAIL ADDRESS:
STREET 1: 40 ROWES WHARF
CITY: BOSTON
STATE: MA
ZIP: 02210
0001521894
S000033569
GMO U.S. Core Equity Series Fund
C000103077
Class R6
C000108415
Class R4
C000108416
Class R5
0001521894
S000035210
Quality Series Fund
C000108318
Class R4
C000108319
Class R5
C000108320
Class R6
0001521894
S000035211
Core Plus Bond Series Fund
C000108321
Class R4
C000108322
Class R5
C000108323
Class R6
0001521894
S000035212
International Bond Series Fund
C000108324
Class R4
C000108325
Class R5
C000108326
Class R6
0001521894
S000035213
Emerging Country Debt Series Fund
C000108327
Class R4
C000108328
Class R5
C000108329
Class R6
0001521894
S000035214
U.S. Equity Allocation Series Fund
C000108330
Class R4
C000108331
Class R5
C000108332
Class R6
0001521894
S000035215
International Equity Allocation Series Fund
C000108333
Class R4
C000108334
Class R5
C000108335
Class R6
0001521894
S000035216
Global Equity Allocation Series Fund
C000108336
Class R4
C000108337
Class R5
C000108338
Class R6
0001521894
S000035217
Global Asset Allocation Series Fund
C000108339
Class R4
C000108340
Class R5
C000108341
Class R6
0001521894
S000035218
Benchmark-Free Allocation Series Fund
C000108342
Class R4
C000108343
Class R5
C000108344
Class R6
0001521894
S000035220
U.S. Intrinsic Value Series Fund
C000108347
Class R4
C000108348
Class R5
C000108349
Class R6
0001521894
S000035221
U.S. Growth Series Fund
C000108350
Class R4
C000108351
Class R5
C000108352
Class R6
0001521894
S000035222
International Core Equity Series Fund
C000108353
Class R4
C000108354
Class R5
C000108355
Class R6
0001521894
S000035223
International Large/Mid Cap Value Series Fund
C000108356
Class R4
C000108357
Class R5
C000108358
Class R6
0001521894
S000035224
International Growth Equity Series Fund
C000108359
Class R4
C000108360
Class R5
C000108361
Class R6
0001521894
S000035225
Developed World Stock Series Fund
C000108362
Class R4
C000108363
Class R5
C000108364
Class R6
0001521894
S000035226
Foreign Series Fund
C000108365
Class R4
C000108366
Class R5
C000108367
Class R6
0001521894
S000035227
Emerging Countries Series Fund
C000108368
Class R4
C000108369
Class R5
C000108370
Class R6
N-PX
1
v728133-2_npx.txt
N-PX
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811-22564
GMO Series Trust
(Exact name of registrant as specified in charter)
40 Rowes Wharf Boston, MA 02110
(Address of principal executive offices) (Zip code)
J.B. Kittredge, Principal Executive Officer
GMO Trust
40 Rowes Wharf Boston, MA 02110
(Name and address of agent for service)
Registrant's telephone number, including area code: (617) 330-7500
Date of fiscal year end: 4/30/12
Date of reporting period: 03/01/12 - 06/30/12
Item 1. Proxy Voting Record.
Disclose the following information for each matter relating to a portfolio
security considered at any shareholder meeting held during the period covered by
the report and with respect to which the registrant was entitled to vote:
******************************* FORM N-Px REPORT *******************************
ICA File Number: 811-22564
Reporting Period: 07/01/2011 - 06/30/2012
GMO Series Trust
=================== GMO International Equity Allocation Fund ===================
There is no proxy voting activity for the fund, as the fund did not hold any
votable positions during the reporting period.
========== END NPX REPORT
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
(Registrant) GMO Series Trust
---------------------------------------------------------------
By (Signature and Title)*
/s/ J.B. Kittredge
-------------------------------------------------
J.B. Kittredge, Principal Executive Officer
Date August 17, 2012
---------------------------------------------------------------------
*Print the name and title of each signing officer under his or her signature.
2